PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive: RNA-seq data using specimens from CML patients with primary BCR-ABL1-independent resistance revealed that both PSMD1 and PSMD3 are upregulated in BP-CML patient samples compared with patients in the chronic or accelerated phases of the disease (Fig. 3A, B).